SEC Form 4 · accession 0001209191-18-005410
INCYTE CORP · INCY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Yao Wenqing
Officer — EVP, Head of Discovery Chem
Period of report
Jan 23, 2018
Accepted (ET)
Jan 25, 2018 · 4:52 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000879169
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $94.63 | Jan 23, 2018 | A | 12,128 | A | — | Jan 22, 2028 | Common Stock | 12,128 | 12,128 | D |
| Employee Stock Option (right to buy)F2 | $95.34 | Jan 24, 2018 | A | 21,167 | A | — | Jan 23, 2028 | Common Stock | 21,167 | 21,167 | D |
Explanation of responses
- F1Beginning January 23, 2018, options become exercisable in 37 installments, with the first 25.00% vesting on July 5, 2018 and the remainder vesting monthly over three years.
- F2Beginning January 24, 2018, options become exercisable in full on January 24, 2022.